Lingshu Wang

12.4k citations
86 papers · 9.8k · 10 hit papers · h-index 38

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • Viral Infections and Outbreaks Research
  • Virology top 1%
    • HIV Research and Treatment

Papers in

    • SARS-CoV-2 and COVID-19 Research 42
    • Viral Infections and Outbreaks Research 2
    • HIV Research and Treatment 12

Lingshu Wang

81 papers receiving 9.6k citations

Lingshu Wang's Hit Papers

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron 2022 · 169 citations
1690+4+8Years since publication4008001.2k

Peers

Lingshu Wang
Comparison fields: 5 of 129
  • Infectious Diseases 5.6k
  • Virology 579
  • Epidemiology 1.4k
  • Immunology 806
  • Biomaterials 292
Replace Hanne Andersen Elyard with:
Hanne Andersen Elyard United States
Andrea Carfı́ United States
Wing‐Pui Kong United States
Masaru Kanekiyo United States
Aaron G. Schmidt United States
Julie E. Ledgerwood United States
Peter Pushko United States
Hannah L. Turner United States
Eun Sung Yang United States
Lingshu Wang relative to Hanne Andersen Elyard United States Hanne Andersen Elyard's profile →
Citations per field
00.5×1.5×1.8×
Hanne Andersen Elyard · 1×
Citations per year

Countries citing papers authored by Lingshu Wang

Since Specialization
Citations

This map shows the geographic impact of Lingshu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingshu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingshu Wang more than expected).

Fields of papers citing papers by Lingshu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingshu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingshu Wang. The network helps show where Lingshu Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Lingshu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lingshu Wang Line = papers co-authored together Lingshu Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.

#Work
1
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Hit paper breakdown →
20201290
2
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Hit paper breakdown →
2020864
3
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Hit paper breakdown →
2017816
4
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Hit paper breakdown →
2013761
5
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
Hit paper breakdown →
2015597
6
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Hit paper breakdown →
2021427
7
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Hit paper breakdown →
2022333
8 2014294
9 2016281
10 2015256
11 2016238
12 2021235
13
Broadly neutralizing antibodies target the coronavirus fusion peptide
Hit paper breakdown →
2022192
14 2016190
15
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Hit paper breakdown →
2022169
16 2019166
17 2021162
18 2018139
19
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
Hit paper breakdown →
2022135
20 2022134

About Lingshu Wang

Lingshu Wang is a scholar working on Infectious Diseases, Virology, Epidemiology, Genetics and Animal Science and Zoology, having authored 86 papers that have together received 9.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (42 papers), HIV Research and Treatment (12 papers), Influenza Virus Research Studies (9 papers), Virus-based gene therapy research (8 papers), Mathematical and Theoretical Epidemiology and Ecology Models (7 papers), Animal Virus Infections Studies (4 papers), Nonlinear Waves and Solitons (2 papers) and Viral Infections and Outbreaks Research (2 papers). The work is most often cited by research in Infectious Diseases (5.6k citations), Virology (579 citations), Epidemiology (1.4k citations), Immunology (806 citations) and Biomaterials (292 citations). Lingshu Wang has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Wing‐Pui Kong, Barney S. Graham, Gary J. Nabel, Masaru Kanekiyo, Hadi Mohamad Yassine, Patrick M. McTamney, Chih‐Jen Wei, Jeffrey C. Boyington, Srinivas S. Rao and James R. R. Whittle. Their work appears in journals such as Journal of Virology, Cell Reports, Science Translational Medicine, Nature Medicine and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact